Secondary Hypertension: When High Blood Pressure is Caused by Another Condition

Understanding Primary vs. Secondary Hypertension

Hypertension is categorized into two main types: primary (essential) hypertension and secondary hypertension. Primary hypertension accounts for approximately 90% to 95% of all adult cases. It develops gradually over many years and is the result of a complex interaction of genetic factors, aging, and lifestyle behaviors (such as high sodium intake and physical inactivity). In contrast, secondary hypertension represents the remaining 5% to 10% of cases. It is characterized by high blood pressure that is directly caused by an identifiable underlying medical condition or medication. Identifying secondary hypertension is clinically critical because treating or resolving the underlying cause can often cure or significantly improve the patient’s blood pressure control, potentially reducing or eliminating the need for lifelong pharmacotherapy.

Clinical Red Flags for Secondary Hypertension

Because diagnostic testing for all potential causes of secondary hypertension is expensive and unnecessary for every patient, clinicians look for specific clinical clues, or “red flags,” that suggest an underlying etiology. These red flags include:

• Resistant Hypertension: Blood pressure that remains above target despite the concurrent use of three antihypertensive medication classes, which should ideally include a long-acting diuretic.
• Sudden or Severe Onset: Sudden development of severe hypertension in a patient who previously had normal blood pressure, or a sudden loss of blood pressure control in a previously stable patient.
• Extremes of Age: Development of Stage 2 hypertension before puberty or onset of hypertension before age 30 (especially in patients without obesity or a family history) or after age 55.
• Target Organ Damage: Development of disproportionately severe damage to target organs (such as left ventricular hypertrophy, retinopathy, or kidney damage) relative to the duration or severity of the high blood pressure.
• Unexplained Hypokalemia: Low potassium levels in the blood, especially when not taking diuretics, which can indicate primary aldosteronism.

When these red flags are present, a systematic diagnostic evaluation is indicated.

Common Underlyng Causes of Secondary Hypertension

The causes of secondary hypertension span several organ systems, primarily involving the kidneys, endocrine system, and cardiovascular structure:

1. Renal Parenchymal Disease (Chronic Kidney Disease): This is the most common cause of secondary hypertension. Elevated blood pressure occurs due to impaired sodium excretion, volume expansion, and activation of the renin-angiotensin-aldosterone system (RAAS) caused by renal ischemia. In a reciprocal relationship, uncontrolled hypertension further accelerates the progression of kidney disease.
2. Renovascular Hypertension (Renal Artery Stenosis): Narrowing of one or both renal arteries decreases blood flow to the kidneys, prompting them to secrete large amounts of renin to restore perfusion pressure. This renin release increases angiotensin II and aldosterone, causing severe vasoconstriction and fluid retention. The two primary causes are fibromuscular dysplasia (most common in young women) and atherosclerosis (most common in older adults).
3. Primary Aldosteronism (Conn’s Syndrome): Caused by unilateral adrenal adenomas or bilateral adrenal hyperplasia, this endocrine disorder involves the autonomous overproduction of aldosterone, leading to sodium retention, potassium wasting, and volume expansion. Screening is performed using the aldosterone-to-renin ratio (ARR).
4. Obstructive Sleep Apnea (OSA): Chronic intermittent nocturnal hypoxia triggers recurrent surges in sympathetic nervous system activity and catecholamine release. This nocturnal sympathetic activation persists into the daytime, contributing to sustained hypertension and a lack of normal nocturnal blood pressure dipping.
5. Pheochromocytoma: A rare catecholamine-secreting tumor of the adrenal medulla or extra-adrenal chromaffin tissue. It presents with paroxysmal hypertension and the classic triad of headache, palpitations, and diaphoresis (sweating).
6. Cushing’s Syndrome: Cortisol excess, whether endogenous (due to an ACTH-secreting pituitary tumor or adrenal tumor) or exogenous (due to corticosteroid therapy), causes hypertension by promoting sodium retention and enhancing vascular reactivity to pressor agents.
7. Coarctation of the Aorta: A congenital narrowing of the aorta that impairs systemic circulation. It presents with hypertension in the upper extremities and delayed, weakened pulses with lower blood pressure in the lower extremities.

For patients diagnosed with these conditions, medical management requires close coordination with specialized care teams.

💡 💡 Clinical Pearl: Drug-Induced Hypertension

Before embarking on an extensive workup for secondary hypertension, clinicians should conduct a meticulous review of all medications, including over-the-counter products. Common agents that can raise blood pressure include nonsteroidal anti-inflammatory drugs (NSAIDs, which block vasodilatory prostaglandins), oral contraceptives, decongestants (such as pseudoephedrine), systemic corticosteroids, and certain stimulants. Discontinuing or substituting these medications can often normalize blood pressure. This is an important step prior to choosing an Overview of Antihypertensive Medications.

Diagnostic Approach and Treatment Paradigms

The diagnostic workup for secondary hypertension is guided by the patient’s history and physical examination. Screening tests may include renal ultrasound or estimated glomerular filtration rate (eGFR) for renal parenchymal disease, duplex renal Doppler or CT angiography for renal artery stenosis, morning plasma aldosterone concentration and renin activity for primary aldosteronism, home sleep study for OSA, and plasma free metanephrines for pheochromocytoma.

Treatment is tailored to the specific cause. For example, continuous positive airway pressure (CPAP) therapy is used for sleep apnea, surgical resection is indicated for unilateral aldosterone-producing adenomas and pheochromocytomas, and renal artery stenting or angioplasty may be considered for select patients with renal artery stenosis. In cases of chronic kidney disease, optimizing blood pressure control with RAAS blockers is vital to slow renal decline. Resolving the primary condition remains the definitive strategy for curing or significantly mitigating secondary hypertension.

💡 Frequently Asked Questions (FAQ)

📚 References & Sources

1. Rimoldi, S. F., et al. (2014). Secondary arterial hypertension: when, who, and how to screen? European Heart Journal, 35(19), 1245-1254.
2. Calhoun, D. A., et al. (2008). Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association. Circulation, 117(25), e510-e526.
3. Young, W. F. (2007). Primary aldosteronism: renaissance of a common cause of secondary hypertension. Molecular and Cellular Endocrinology, 277(1-2), 6-10.